Udho Thadani, MD, discusses medicine, food and the arts

Raible, Eric
June 2008
Cardiology Today;Jun2008, Vol. 11 Issue 6, p29
An interview with founding member of the "Cardiology Today" editorial board Dr. Udho Thadani is presented. When asked what he considers to be the biggest success in his specialty, he mentioned that he always loved taking care of patients and his main focus now is studying drug effects in people to determine its efficacy. He considers his mentor as Dr. K. L. Wig, a professor of medicine from All India Institute of Medical Sciences (AIIMS), and Dr. Clive Aber. He states that his favorite restaurant in Las Vegas is Bouchon.


Related Articles

  • CE Questions.  // Drug Formulary Review;May2008 Supplement, Vol. 24, Special section p4 

    A quiz concerning on the clinical efficacy, safety, and effectiveness of the therapeutic agent Rivastigmine is presented.

  • CHEMIMAGE OFFERS BIOEQUIVALANCE TECHNOLOGY FOR DRUG MAKERS.  // Biotech Business;Apr2009, Vol. 22 Issue 4, p7 

    The article reports on the plan of Pittsburgh, Pennsylvania-based ChemImage to help genetic drug makers become the first to achieve bioequivalence for nasal spray suspensions and inhalation products. According to the article, it will do so by providing a faster and more accurate way to determine...

  • Failure of Two Commercial Indexes and Spectral Parameters to Reflect the Pharmacodynamic Effect of Desflurane on EEG. Sascha Kreuer; Jörgen Bruhn; Richard Ellerkmann; Stephan Ziegeler; Darius Kubulus; Wolfram Wilhelm // Journal of Clinical Monitoring & Computing;Apr2008, Vol. 22 Issue 2, p149 

    Abstract Objective  We compared two PK/PD models, one with and one without a plateau effect. Bispectral (BIS, Aspect Medical Systems, Natick, MA, version XP) and Narcotrend™ (NCT, MonitorTechnik, Bad Bramstedt, Germany, Version 4.0) indices were used as an...

  • A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients. Ally, R.; Schurmann, D.; Kreisel, W.; Carosi, G.; Aguirrebengoa, K.; Dupont, B.; Hodges, M.; Troke, P.; Romero, A.J. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1447 

    Discusses a study which compared the efficacy, safety and tolerability of voriconazole and fluconazole in immunocompromise patients with mycology- and biopsy-proven esophageal candidiasis. Background of the patients; Findings of efficacy analysis; Safety of the medications.

  • Getting the right drug into the right patient. Marshall, Andrew // Nature Biotechnology;Dec98 Supplement 2, Vol. 16, p9 

    Pharmacogenomics will help explain why drugs work better in some patientsthan in others. It also presents numerous commercial opportunities for bothstartups and established biotechnology companies.

  • Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Stability of Continuous or Extended Infusion Regimens of Carbapenems. Chan, Andy; Song, Jessica C. // Infectious Disease Alert;Feb2011, Vol. 30 Issue 5, p52 

    The article discusses the pharmacokinetics, pharmacodynamics, clinical effectiveness and stability properties of continuous or extended infusion dosing of carbapenem. Pharmacokinetic/pharmacodynamic trials of meraponem have mainly used loading doses ranging from 0.5 grams to 2 grams and doses of...

  • Candesartan and lisinopril.  // Caribbean Health;Jun2001, Vol. 4 Issue 3, p25 

    The article focuses on the study which examines the effectiveness of candesartan and lisinopril drugs. It is stated that the two drugs are compared in patients with Type 2 diabetes, hypertension, and microalbuminuria. The study has included 199 patients aged 30-75 years old. It is found that...

  • Are Effects of Antihypertensive Treatment on Lipoproteins Merely 'Side-Effects'? A Comparison of Prazosin and Metoprolol.  // JAMA: Journal of the American Medical Association;3/10/89, Vol. 261 Issue 10, p1428 

    Discusses the abstract of a research study comparing the efficacy of prazosin and metoprolol. Effects of antihypertensive treatment on lipoproteins; Corresponding differences in the atherogenic index of the patients who participated in the study; Metabolic response of the subjects to the drugs.

  • Quinine.  // Reactions Weekly;1/31/2009, Issue 1237, p20 

    The article describes the case of a 34-year-old man who developed a fixed drug eruption after consuming a drink containing tonic water, which contained quinine. The patient had a history of three episodes of erythematoviolaceous maculae on his right hand over the previous two years. Results of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics